MedPath

深圳万乐药业有限公司

Ownership
-
Established
1990-07-04
Employees
-
Market Cap
-
Website
www.wanle.com.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

33

NMPA:33

Drug Approvals

Bendamustine Hydrochloride for Injection

Product Name
注射用盐酸苯达莫司汀
Approval Number
国药准字H20253886
Approval Date
Apr 15, 2025
NMPA

Bortezomib for Injection

Product Name
注射用硼替佐米
Approval Number
国药准字H20234717
Approval Date
Dec 29, 2023
NMPA

Mirabegron Sustained-release Tablets

Product Name
米拉贝隆缓释片
Approval Number
国药准字H20234650
Approval Date
Dec 13, 2023
NMPA

Ubenimex

Product Name
乌苯美司
Approval Number
国药准字H20067632
Approval Date
Nov 26, 2020
NMPA

Docetaxel Injection

Product Name
希存
Approval Number
国药准字H20205048
Approval Date
Nov 20, 2020
NMPA

Cisatracurium Besilate for Injection

Product Name
注射用苯磺顺阿曲库铵
Approval Number
国药准字H20203524
Approval Date
Oct 15, 2020
NMPA

Docetaxel Injection

Product Name
希存
Approval Number
国药准字H20060127
Approval Date
Sep 29, 2020
NMPA

Eptazocine Hydrobromide Injection

Product Name
氢溴酸依他佐辛注射液
Approval Number
国药准字H20065171
Approval Date
Sep 29, 2020
NMPA

Eptazocine Hydrobromide

Product Name
氢溴酸依他佐辛
Approval Number
国药准字H20060978
Approval Date
Sep 29, 2020
NMPA

Paclitaxel Injection

Product Name
紫杉醇注射液
Approval Number
国药准字H20056879
Approval Date
Mar 13, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.